5 , all six anti‐TAAs autoantibodies showed an increasing trend with time going, whereas they appeared at relatively stable lower levels in control groups.
← all excerpts
Human Proteome Microarray identifies autoantibodies to tumor-associated antigens as serological biomarkers for the diagnosis of hepatocellular carcinoma.
1
—
—